Peptide record

TPDB23022

ACE inhibitor Hypotensive peptide ACE inhibitors Antibacterial Antidiabetic Antihypertensive standard
4 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB23022
ACE inhibitor Hypotensive peptide
ACE inhibitors Antibacterial Antidiabetic Antihypertensive
Anti-infective peptides Cardiometabolic peptides
FermFooDB Peptipedia AHTPDB AHTpin
standard
No
A 4-aa standard-residue multi-activity (ACE inhibitors, Antibacterial, Antidiabetic, and other sources) peptide sequence curated from FermFooDB, Peptipedia, AHTPDB, and other sources, with an available 3D structural model.
Sequence
LPLP
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C22H38N4O5
ARNDCEQGHIKMFSTWYV
LP
438.57
6.02
0
0
2
-0
-2.46
1.100
195.00
Mammalian: 5.5 hour Yeast: 3 min E.coli: 2 min
0
0.00
0
Residue Composition
number
0
A
0
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
0
I
2
L
0
K
0
M
0
F
2
P
0
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 2 K: 0 M: 0 F: 0 P: 2 S: 0 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
4 reviewed residue count
C22H38N4O5 sequence-only estimate (linear, free termini)
438.57 sequence-only estimate (linear, free termini)
6.02 sequence-only estimate (linear, free termini)
-0 sequence-only estimate (linear, free termini)
-2.46 sequence-only estimate (linear, free termini)
1.100 sequence-only estimate (linear, free termini)
438.5594 Activity
438.2833 Activity
Evidence Records 3 records
Evidence 1 Activity

Activity

IC50
ACE inhibitors
720.00 µM
Inhibitor of Angiotensin-Converting Enzyme (ACE) (EC 3.4.15.1) (MEROPS ID: M02-001)
ACE inhibitor
ah

Source & Reference

FermFooDB
Kohmura M., Nio N., Kubo K., Minoshima Y., Munekata E., Ariyoshi Y.
Inhibition of angiotensin-converting enzyme by synthetic peptides of human beta-casein. Agric. Biol. Chem., 53(8), 2107-2114 (1989)
1989
Journal

Other

4
BIOPEP-UWM database of bioactive peptides SMILES: N[C@@]([H])(CC(C)C)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(CC(C)C)C(=O)N1[C@@]([H])(CCC1)C(=O)O InChI=1S/C22H38N4O5/c1-13(2)11-15(23)20(28)25-9-5-7-17(25)19(27)24-16(12-14(3)4)21(29)26-10-6-8-18(26)22(30)31/h13-18H,5-12,23H2,1-4H3,(H,24,27)(H,30,31)/t15-,16-,17-,18-/m0/s1 InChIKey: IFFNGVZLMXVQFA-XSLAGTTESA-N Information concerning Angiotensin-Converting Enzyme (ACE) is available in MEROPS database of proteolytic enzymes (http://merops.sanger.ac.uk/) ID: M02-001 Hypotensive peptide according to the BIOPEP-UWM database of bioactive peptides (ID 10097)
Evidence 2 Activity

Activity

IC50
Antihypertensive
720.00 µM
Inhibitor of Angiotensin-Converting Enzyme (ACE) (EC 3.4.15.1) (MEROPS ID: M02-001)
ACE inhibitor
ah

Source & Reference

AHTPDB FermFooDB
Kohmura M., Nio N., Kubo K., Minoshima Y., Munekata E., Ariyoshi Y.
Inhibition of angiotensin-converting enzyme by synthetic peptides of human beta-casein. Agric. Biol. Chem., 53(8), 2107-2114 (1989)
1989
Journal

Other

Source Activity Label Source Definition
Antihypertensive
AHTPDB manually curated experimentally validated antihypertensive peptide annotation.
4
BIOPEP-UWM database of bioactive peptides SMILES: N[C@@]([H])(CC(C)C)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(CC(C)C)C(=O)N1[C@@]([H])(CCC1)C(=O)O InChI=1S/C22H38N4O5/c1-13(2)11-15(23)20(28)25-9-5-7-17(25)19(27)24-16(12-14(3)4)21(29)26-10-6-8-18(26)22(30)31/h13-18H,5-12,23H2,1-4H3,(H,24,27)(H,30,31)/t15-,16-,17-,18-/m0/s1 InChIKey: IFFNGVZLMXVQFA-XSLAGTTESA-N Information concerning Angiotensin-Converting Enzyme (ACE) is available in MEROPS database of proteolytic enzymes (http://merops.sanger.ac.uk/) ID: M02-001 Hypotensive peptide according to the BIOPEP-UWM database of bioactive peptides (ID 10097)
Evidence 3 Activity

Activity

EC50
Antihypertensive
0.00 µM
Antihypertensive activity in vivo in rats.
hypotensive
hyp

Source & Reference

AHTPDB FermFooDB
Sanchez-Rivera L., Ferreira Santos P., Miralles B., Carron R., Montero J., Recio I.
Peptide fragments from beta-casein f(134–138), HLPLP, generated by the action of rat blood plasma peptidases show potent antihypertensive activity. Food Res. Int., 88, 348-353, 2016
2016
Journal

Other

4
BIOPEP-UWM database of bioactive peptides SMILES: N[C@@]([H])(CC(C)C)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(CC(C)C)C(=O)N1[C@@]([H])(CCC1)C(=O)O InChI=1S/C22H38N4O5/c1-13(2)11-15(23)20(28)25-9-5-7-17(25)19(27)24-16(12-14(3)4)21(29)26-10-6-8-18(26)22(30)31/h13-18H,5-12,23H2,1-4H3,(H,24,27)(H,30,31)/t15-,16-,17-,18-/m0/s1 InChIKey: IFFNGVZLMXVQFA-XSLAGTTESA-N Inhibitor of Angiotensin-Converting Enzyme (ACE) (EC 3.4.15.1) (MEROPS ID: M02-001) according to the AHTPDB database the BIOPEP-UWM database of bioactive peptides (ID 2665), the EROP-Moscow database, the MBPDB database
Additional Detail Fields 1 fields
4